Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?
Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.
North General, MSK, Form Cancer Prevention Center.
Human Genome Consortium Completes “Working Draft”.
NCI Plans $40M In Grants For Cancer Outcomes Studies.
Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.
FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.
Sustained-Release Leuprolide Under Study In Phase III Trial.
Celgene Signs CRADA With NCI For Development Of CDC-501.
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
